Navigation Links
Patient Recruitment Expert CSS Tapped to Host Master Workshop and Roundtable Discussions at Annual SCRS Site Solutions Summit Conference in October
Date:9/26/2013

GLEN BURNIE, Md., Sept. 26, 2013 /PRNewswire/ -- Clinical Site Services (CSS), the leader in global patient recruitment and enrollment solutions for the clinical research industry, is pleased to announce their participation in the annual Site Solutions Summit sponsored by the Society for Clinical Research Sites. 

Now in its 8th year, the Site Solutions Summit is an annual conference dedicated to helping clinical research sites reach optimal performance and achieve success. The Summit will be held October 11-13 in Amelia Island, Florida, and will host an array of workshops, roundtables, and networking opportunities focusing on "fresh strategies for remarkable performance" – the theme to this year's conference. As a Global Impact Partner of the SCRS, CSS will be hosting a Master Workshop, leading roundtable discussions as well as exhibiting information on their innovative approach to patient recruitment and enrollment solutions.

The CSS Master Workshop on October 11, titled, "Keeping up with the Changing Recruitment and Retention Environment," will be hosted by CSS President, Chris Trizna and Vice President, Jennifer Whitlock. For the third year, SCRS has asked CSS to lend their expertise in this area, as timely patient recruitment continues to be a challenge expressed by most investigative sites. The workshop will focus on how difficult protocols and competitive enrollment add up to potential difficulty in meeting patient recruitment and retention goals. Trizna explains, "We want to address how each site can arm themselves with the right plan of action, strategies and tactics to consistently enroll their studies."

"Our workshop is designed so that attendees will come away with solutions they can implement immediately," shared Trizna. "For example, helping them to understand th
'/>"/>

SOURCE Clinical Site Services
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
2. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
3. Watching, Reading and Listening: A New Way to Interact with Patient Information
4. Phreesia identifies over 26% of patients who require additional autism evaluation
5. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
8. New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinsons disease
9. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
10. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
11. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... BAUDETTE, Minn. , July 28, 2014  ANI ... that the Company plans to release its second quarter ... 2014, before the opening of the U.S. financial markets. ... Investor Relations section of the Company,s website, www.anipharmaceuticals.com ... and Chief Executive Officer, and Charlotte C. Arnold ...
(Date:7/28/2014)... 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... Financial Results and Highlights Conference CallWhen:Monday, August 4 at ... How:Live on the Internet. Simply log onto our website ... the live event, a replay of the webcast will ... . ABOUT ISIS PHARMACEUTICALS, INC. Isis is ...
(Date:7/28/2014)... , Germany and ... , Collaboration aims to create and ... to guide the use of IRESSA  for non-small cell ... build on QIAGEN,s FDA-approved  therascreen   EGFR test and is ... of automated instruments  Project enabled by AstraZeneca ...
Breaking Medicine Technology:ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 3QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 4QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 5QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 6
(Date:7/28/2014)... researchers report that an alternative to the traditional handshake ... experiments, the scientists found that clasping hands transferred about ... other than what is known as a fist bump. ... a cultural substitute for the firm gripping of hands. ... of the American Journal of Infection Control . ...
(Date:7/28/2014)... Washington, DC (PRWEB) July 28, 2014 ... recipe app for iOS, App is available on iTunes for ... first of its kind, Audio Chef allows you to listen ... gourmet cuisine the easy way: simply get out the ingredients ... no need to measure or prepare ingredients ahead of time, ...
(Date:7/28/2014)... meal you,ve ordered at a restaurantor when something ... your brain. , These waves are called ... cellsboth excitatory and inhibitoryplaying together in an orchestrated ... waves have been associated with higher-level brain function, ... to schizophrenia, Alzheimer,s disease, autism, epilepsy and other ...
(Date:7/28/2014)... 28, 2014 UT Southwestern Medical Center cancer ... irreversibly interferes with the activity of a mutated ... , The molecule, SML-8-73-1 (SML), interferes with the ... homolog. The gene produces proteins called K-Ras that ... result in normal cells dividing uncontrollably and turning ...
(Date:7/28/2014)... 2014 The report, “Blowing Agents ... - Trends and Forecasts to 2019” defines and ... and forecasting of the global consumption volume and ... tables with 39 figures spread through 226 Pages ... http://www.marketsandmarkets.com/Market-Reports/blowing-agents-market-71329121.html , Blowing agents are highly utilized ...
Breaking Medicine News(10 mins):Health News:'Fist Bump' May Beat Handshake for Cleanliness 2Health News:'Fist Bump' May Beat Handshake for Cleanliness 3Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 3Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 4Health News:Memory relies on astrocytes, the brain's lesser known cells 2Health News:Memory relies on astrocytes, the brain's lesser known cells 3Health News:UTSW cancer researchers identify irreversible inhibitor for KRAS gene mutation 2Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 2Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 3Health News:Blowing Agents Market is Poised to Reach 452.0 Kilotons at CAGR of 5.8% by 2019 – Report by MarketsandMarkets 4
... debate is still on. Is Hormone Replacement Therapy (HRT), good ... caution. The treatment, which targets menopausal women by giving them ... two -edged sword. Its risks such as breast cancer, and ... traumatic menopausal symptoms. This was mainly due to a 2002 ...
... have criticized Prime Minister John Howard for calling for a ... there was no evidence to suggest migrants were responsible for ... Minister Howard had made the suggestion in an interview to ... sharp rise in HIV cases. ,Don Baxter, ...
... forces to perfect a powerful new weapon in the war ... spores. //Their results are published in the prestigious journal Science, ... to use lasers to detect anthrax in real time as ... now,” says Marlan Scully, Distinguished Professor of Physics at Texas ...
... sexually transmitted disease, has become so drug resistant now ... options to treat this serious disease. ,Doctors prescribe ... ofloxacin, and levofloxacin) as a treatment for the disease. ... and Prevention (CDC) says that the sexual disorder-that affects ...
... are now looking at lactate with a much more ... the brain in the immediate //hours after a traumatic ... they are right, it could change how emergency room ... injuries in the first critical hours after injury. ...
... Viagra, Cialis, and Levitra are the answer to their ... a new report from Harvard Medical School, these pills ... pressures that frequently accompany erectile dysfunction (ED). ... man is feeling sexual desire for his partner. If ...
Cached Medicine News:Health News:Hormone Replacement Therapy – To Choose Or No 2Health News:HIV Experts Criticize Australian PM's Suggestion for Ban on Entry of HIV-infected 2Health News:Physicists Unite To Develop Anthrax Detection Method 2Health News:Physicists Unite To Develop Anthrax Detection Method 3Health News:Physicists Unite To Develop Anthrax Detection Method 4Health News:Scientists Concerned About Gonorrhea’s Drug Resistanc 2Health News:Study Challenges Conventional Treatment of Traumatic Brain Injury 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: